Skip to content

Dermato Dr JASON

Active
Private limited companyfounded 2007active for 19 yearsLa Neuville 6, 4877 Olne, BelgiumKBO/BCE: BE 0891.240.552

From the official registers: KBO 18 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dermato Dr JASON has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €200,289 and a net result of €47,583. Equity has been growing by about 7.8% per year since 2018. The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 03-08-2007 Normal situation
Activity
“L’exercice de la médecine par le ou les associés qui la composent,lesquels sont exclusivement…” (deed in French)From the articles, 7 activitiesNo NACE code in the KBO yet
Establishment unit
2.302.763.865 4877 Olne, since 01-08-2007
Financial year end
31 December
Peppol
Not found in the Peppol Directory

Board and ownership

Board

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€73,923
▲ 17.0%
Turnover
≈ €220,000
estimated
Profit
€47,583
▲ 19.4%
Equity
€200,289
▲ 7.9%
Total assets
€364,829
▲ 18.9%
Filed on 22-05-2026, 70 days before the deadlinePDF
Score breakdownlowers riskSize: total assets €364,829Liquidity: current ratio 2.27, cash €363,063Equity €200,289 (54.9% of total assets)Figures for financial year 2025 (filed on 22-05-2026)Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 63% of micro companies without a NACE code
Financial strength · tick: 2024
Strong
Solvency 80-6
equity 54.9% of total assets
Liquidity 79-3
short-term debt 43.8% · cash 99.5%
Profitability 85=
return on assets 13.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025lowest value 06-2025: < 0.1%● unchanged vs 05-2025lowest value 07-2025: < 0.1%● unchanged vs 06-2025lowest value 08-2025: < 0.1%● unchanged vs 07-2025lowest value 09-2025: < 0.1%● unchanged vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025lowest value 11-2025: < 0.1%● unchanged vs 10-2025lowest value 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026highest value 03-2026: < 0.1%● unchanged vs 02-2026highest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €19,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.27 (2.57 in 2024), above the usual 1.5. Short-term debt is 43.8% and cash 99.5% of total assets. 45.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 47% of them on solvency, 72% on liquidity, 68% on profitability and 65% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Size: total assets €364,829
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.27, cash €363,063
NBB · annual accounts
lowers risk · Equity €200,289 (54.9% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 22-05-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-05-2026, 70 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
70 days early
2024
97 days early
2023
75 days early
2022
82 days early
2021
94 days early
2020
92 days early
2019
7 days early
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 7 accounts on average 74 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 May (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €47,583 8 years View

Documents

Annual accounts at the NBB

All 18 annual accounts

Articles and registers

Key facts about Dermato Dr JASON

What is the company number of Dermato Dr JASON?
The company number of Dermato Dr JASON is 0891.240.552. The VAT number is the same number with BE in front: BE 0891.240.552.
Where is Dermato Dr JASON based?
The registered office is at La Neuville 6, 4877 Olne.Company details
What is the legal form of Dermato Dr JASON?
The legal form of Dermato Dr JASON is Private limited company (BV).
When was Dermato Dr JASON founded?
Dermato Dr JASON was founded on 03-08-2007.
Is Dermato Dr JASON still active?
Yes, Dermato Dr JASON is an active enterprise in the KBO register.
What is the turnover of Dermato Dr JASON?
The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €73,923 and 2,678 comparable companies of the same size. It probably lies between €150,000 and €390,000. It is a rough estimate.Financials
Is Dermato Dr JASON profitable?
In financial year 2025, Dermato Dr JASON made a profit of €47,583.
Where can I find the annual accounts of Dermato Dr JASON?
Dermato Dr JASON filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of Dermato Dr JASON due?
Dermato Dr JASON must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.